EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer Therapy-Induced Right Ventricular Systolic and Diastolic Dysfunction Assessed Using Conventional Echocardiographic Indices: A Prospective Observational Study

Svetoslava Elefterova Slavcheva, Nikolay Conev, Atanas Angelov

Diagnostics · 13.11.2026 · 16 (22) · 3764

DOI: 10.3390/diagnostics16223764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 13.11.2026. Verfasst von Svetoslava Elefterova Slavcheva und 2 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Fund of Medical University of Varna.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cancer treatment can impair right ventricular (RV) systolic and diastolic function by altering cardiomyocyte metabolism and inducing cell death. The incidence and prognosis of cancer therapy-induced RV involvement remain uncertain. We assessed RV diastolic changes and their association with systolic RV and LV dysfunction in cancer patients.

Methods

We prospectively observed 60 adults (91.7% female, aged 31 to 74 years) with breast or gastrointestinal cancer receiving chemotherapy for a median of 381 days (IQR 187, 464), excluding those with cardiovascular or pulmonary disease. RV diastolic function was assessed using the 2010 right heart echocardiographic guidelines. RV systolic dysfunction was defined by abnormal values in at least two of the following RV indices: fractional area change (RVFAC), systolic tissue Doppler velocity (RVS’), tricuspid annular plane systolic excursion, or myocardial performance index. LV dysfunction was defined by abnormal LV ejection fraction or average systolic LV tissue Doppler velocity.

Results

RV systolic dysfunction was found in 7 patients (11.7%), RV diastolic dysfunction in 12 (30.7%), and LV dysfunction in 11 (18.3%). Generalised estimating equations showed early decreases in RVS’ and RVFAC at the first month (β = −0.68, p = 0.016; β = −2.2, p = 0.006), and later changes in RV early diastolic tissue velocity (RVe′) and the ratio of early RV filling velocity (RVE) to RVe′ (RVE/e′) at the third month (β = −1.03, p = 0.005; β = 0.35, p = 0.034). Higher RVFAC values were linked to lower odds of LV dysfunction (OR 0.88, p = 0.002). RVe′ was associated with RV systolic dysfunction (OR 0.61, p < 0.001), with a threshold of 10 cm/s (AUC 0.81; 95% CI: 0.69, 0.93).

Conclusions

Conventional echocardiographic parameters may facilitate the detection of RV systolic and diastolic dysfunction during cancer therapy. Early alterations and the prognostic value of RV parameters support the necessity for their routine monitoring.

Förderung

  • Science Fund of Medical University of Varna

Zitieren

APA

Slavcheva, S. E., Conev, N., & Angelov, A. (2026). Cancer Therapy-Induced Right Ventricular Systolic and Diastolic Dysfunction Assessed Using Conventional Echocardiographic Indices: A Prospective Observational Study. Diagnostics, 16(22), 3764. https://doi.org/10.3390/diagnostics16223764

Vancouver

Slavcheva SE, Conev N, Angelov A. Cancer Therapy-Induced Right Ventricular Systolic and Diastolic Dysfunction Assessed Using Conventional Echocardiographic Indices: A Prospective Observational Study. Diagnostics. 2026;16(22):3764. doi:10.3390/diagnostics16223764

BibTeX
@article{Slavcheva2026,
  author = {Slavcheva, Svetoslava Elefterova and Conev, Nikolay and Angelov, Atanas},
  title = {Cancer Therapy-Induced Right Ventricular Systolic and Diastolic Dysfunction Assessed Using Conventional Echocardiographic Indices: A Prospective Observational Study},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {3764},
  doi = {10.3390/diagnostics16223764}
}
Kostenlos starten →